Softhale Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$110M
- Investors
-
1
Softhale General Information
Description
Developer of inhalable therapeutic devices intended to improve respiratory treatments. The company's devices incorporate a proprietary set of technical configurations to spray a propellant-free liquid formulation in a highly efficient way to get the medication pass the natural curve of the throat providing time to naturally breathe in the medication, enabling physicians to get the medication deep into patient's lungs and relieve them from chronic respiratory conditions.
Contact Information
Website
www.softhale.comCorporate Office
- BioVille, Agoralaan
- Building Abis
- 3590 Diepenbeek
- Belgium
Corporate Office
- BioVille, Agoralaan
- Building Abis
- 3590 Diepenbeek
- Belgium
Softhale Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 31-Mar-2021 | $110M | Completed | Generating Revenue | ||
| 6. Early Stage VC | 01-Jan-2020 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series B) | 01-Mar-2019 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 23-Nov-2016 | Completed | Startup | |||
| 3. Early Stage VC (Series A) | 20-Jun-2016 | Completed | Startup | |||
| 2. Grant | 01-Jan-2016 | $1.09M | Completed | Startup | ||
| 1. Seed Round | 01-Jan-2014 | Completed | Startup |
Softhale Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference A | ||||||||
| Preference A | ||||||||
| Preference A | 2,381 | $22.78 | $22.78 | 1x | $22.78 | 1.1% |
Softhale Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| New Rhein Healthcare | Venture Capital | Minority | ||
| Vesalius Biocapital Partners | Venture Capital | Minority |
Softhale FAQs
-
When was Softhale founded?
Softhale was founded in 2012.
-
Where is Softhale headquartered?
Softhale is headquartered in Diepenbeek, Belgium.
-
What industry is Softhale in?
Softhale’s primary industry is Therapeutic Devices.
-
Is Softhale a private or public company?
Softhale is a Private company.
-
What is the current valuation of Softhale?
The current valuation of Softhale is .
-
What is Softhale’s current revenue?
The current revenue for Softhale is .
-
How much funding has Softhale raised over time?
Softhale has raised $3.44M.
-
Who are Softhale’s investors?
New Rhein Healthcare and Vesalius Biocapital Partners have invested in Softhale.
-
When was Softhale acquired?
Softhale was acquired on 31-Mar-2021.
-
Who acquired Softhale?
Softhale was acquired by Sino Biopharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process